Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:8 Issue:9 Number:18 ISSN#:2563-5476
RCT
ACE Report #12326
Ace Report Cover Spine

Blood Loss and Time to Ambulation Decreased in Lumbar Interbody Fusion Patients with TXA vs Placebo


Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Tranexamic Acid for Blood Loss after Transforaminal Posterior Lumbar Interbody Fusion Surgery: A Double-Blind, Placebo-Controlled, Randomized Study.

Biomed Res Int. 2020 Aug 14;2020:8516504

Contributing Authors: B He Y Li S Xu Y Ou J Zhao

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Forty patients undergoing transforaminal lumbar interbody fusion were randomized into receiving tranexamic acid or a placebo. Outcomes of interest included blood loss, postoperative drainage volume, time to drainage removal, time to ambulation, length of hospital stay, hemoglobin (Hb) levels post-operation, and the incidence of adverse events. Results demonstrated that intraoperative blood loss wa...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.